Press release
Peritoneal Cancer Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Discover the latest drugs and treatment options in the Peritoneal cancer Pipeline. Dive into DelveInsight's comprehensive report today! @ Peritoneal Cancer Pipeline Outlook [https://www.delveinsight.com/sample-request/peritoneal-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Peritoneal cancer Pipeline Report
* In May 2025, Corcept Therapeutics announced a Phase 2 study to evaluate efficacy and safety of intermittent dosing of relacorilant in combination with nab-paclitaxel and bevacizumab in patients with ovarian cancer.
* In May 2025, Imunon conducted a phase I/II trial to evaluate the safety, dosing, efficacy, and biological activity of adding IMNN-001 to chemotherapy + BEV compared to chemotherapy + BEV alone.
* In May 2025, Merck Sharp & Dohme LLC organized a study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and If people who take sacituzumab tirumotecan with or without bevacizumab live longer without the cancer getting worse than those who receive standard of care treatment.
* DelveInsight's Peritoneal Cancer Pipeline report depicts a robust space with 55+ active players working to develop 60+ pipeline therapies for Peritoneal Cancer treatment.
* The leading Peritoneal Cancer Companies such as Zentalis Pharmaceuticals, Zenith Epigenetics, Mersana Therapeutics, Seagen, Sutro Biopharma, Shattuck Labs, Clover Biopharmaceuticals, Rhizen Pharmaceutical, Oncoinvent, ImmunoGen, Arsenal Biosciences, EMD Serono Research & Development Institute, Medicenna Therapeutics, Array BioPharma and others.
* Promising Peritoneal Cancer Pipeline Therapies such as Avastin, Docetaxel, BIBF 1120, epothilone b, Trabectedin, DOXIL, Dexamethasone, Bevacizumab, CP-547,632, Paclitaxel , and others.
Stay ahead with the most recent pipeline outlook for Peritoneal Cancer. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Peritoneal Cancer Treatment Drugs [https://www.delveinsight.com/sample-request/peritoneal-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Peritoneal Cancer Emerging Drugs Profile
* Masitinib: AB Science
Masitinib is an orally administered tyrosine kinase inhibitor. It modulates the activity of mast cells and macrophages, important cells for immunity, through targeting a limited number of kinases without inhibiting, at therapeutic doses, kinases associated with known toxicities. Based on its unique mechanism of action, masitinib can be developed in a large number of conditions in oncology, in inflammatory diseases, and in certain diseases of the central nervous system. Masitinib's mechanism of action in peritoneal cancer involves inhibiting tumor growth by targeting specific kinases like KIT and PDGFR, crucial for cancer progression, without causing general toxicity. Currently, the drug is in Phase III stage of its clinical trial for the treatment of peritoneal cancer.
* Azenosertib: Zentalis Pharmaceuticals
Azenosertib is a potentially first-in-class and best-in-class small molecule Wee1 inhibitor in development for the treatment of cancer. Inhibition of WEE1, a DNA damage response kinase, drives cancer cells into mitosis without being able to repair damaged DNA, resulting in cell death. Currently, there are no FDA-approved WEE1 inhibitors, and we have designed Azenosertib to have advantages over other investigational therapies, including superior selectivity and pharmacokinetic properties. Currently, the drug is in Phase II stage of its clinical trial for the treatment of peritoneal cancer.
* IMGN151: ImmunoGen
IMGN151 is a next-generation ADC, designed to address the unmet needs of cancer patients with tumor types expressing lower levels of folate receptor alpha (FR). IMGN151 comprises an asymmetric, bivalent, biparatopic antibody targeting two independent epitopes of FR, linked to a highly potent maytansinoid derivative, DM21, via a cleavable peptide linker with enhanced stability, longer half-life, and increased bystander activity. Currently, the drug is in Phase I stage of its clinical trial for the treatment of peritoneal cancer.
The Peritoneal Cancer Pipeline Report Provides Insights into
* The report provides detailed insights about companies that are developing therapies for the treatment of Peritoneal Cancer with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Peritoneal Cancer Treatment.
* Peritoneal Cancer Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Peritoneal Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Peritoneal Cancer market
Explore groundbreaking therapies and clinical trials in the Peritoneal Cancer Marketed and Pipeline Drugs. Access DelveInsight's detailed report now! @ New Peritoneal Cancer Drugs [https://www.delveinsight.com/sample-request/peritoneal-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Peritoneal Cancer Companies
Zentalis Pharmaceuticals, Zenith Epigenetics, Mersana Therapeutics, Seagen, Sutro Biopharma, Shattuck Labs, Clover Biopharmaceuticals, Rhizen Pharmaceutical, Oncoinvent, ImmunoGen, Arsenal Biosciences, EMD Serono Research & Development Institute, Medicenna Therapeutics, Array BioPharma and others
Peritoneal Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Oral
* Intravenous
* Subcutaneous
* Parenteral
* Topical
Peritoneal Cancer Products have been categorized under various Molecule types such as
* Recombinant fusion proteins
* Small molecule
* Monoclonal antibody
* Peptide
* Polymer
* Gene therapy
Unveil the future of Peritoneal Cancer Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Peritoneal Cancer Market Drivers and Barriers [https://www.delveinsight.com/sample-request/peritoneal-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Peritoneal Cancer Pipeline Report
* Coverage- Global
* Peritoneal Cancer Companies- Zentalis Pharmaceuticals, Zenith Epigenetics, Mersana Therapeutics, Seagen, Sutro Biopharma, Shattuck Labs, Clover Biopharmaceuticals, Rhizen Pharmaceutical, Oncoinvent, ImmunoGen, Arsenal Biosciences, EMD Serono Research & Development Institute, Medicenna Therapeutics, Array BioPharma and others.
* Peritoneal Cancer Pipeline Therapies- Avastin, Docetaxel, BIBF 1120, epothilone b, Trabectedin, DOXIL, Dexamethasone, Bevacizumab, CP-547,632, Paclitaxel , and others.
* Peritoneal Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Peritoneal Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Get the latest on Peritoneal Cancer Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Peritoneal Cancer Companies, Key Products and Unmet Needs [https://www.delveinsight.com/sample-request/peritoneal-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Contents
* Introduction
* Executive Summary
* Peritoneal cancer: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Peritoneal cancer- DelveInsight's Analytical Perspective
* Late Stage Products (Phase III)
* Masitinib: AB Science
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* Azenosertib: Zentalis Pharmaceuticals
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* IMGN151: ImmunoGen
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Inactive Products
* Peritoneal cancer Key Companies
* Peritoneal cancer Key Products
* Peritoneal cancer- Unmet Needs
* Peritoneal cancer- Market Drivers and Barriers
* Peritoneal cancer- Future Perspectives and Conclusion
* Peritoneal cancer Analyst Views
* Peritoneal cancer Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=peritoneal-cancer-pipeline-appears-robust-with-55-key-pharma-companies-actively-working-in-the-therapeutics-segment-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/peritoneal-cancer-pipeline-insight
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peritoneal Cancer Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight here
News-ID: 4027002 • Views: …
More Releases from ABNewswire
Global Baby Wipes Market to grow at a CAGR of 5.20% by 2030, Evaluates DelveInsi …
The Key Baby Wipes Companies in the market include - Johnson & Johnson Private Limited, Nice-Pak Products, Inc., Himalaya Wellness Company, Farlin-Global, Procter & Gamble, Unicharm Corporation, Albaad, Irish Breeze, Blue Bear Protection, Yoboo, Hindustan Unilever Limited, Linette Hellas SA., Canopus Wet Wipe, Dabur India Ltd., Kimberly Clark, Coterie Baby, Inc., Niki's Natural Wipes, The Honest Company, Inc., Premier Care Industries, Kleen-Pak Products Pte Ltd., and others.
According to DelveInsight's analysis,…
Global Microbial Fermentation Market to grow at a CAGR of 5.24% by 2032, Evaluat …
The Key Microbial Fermentation Companies in the market include - Novozymes A/S, Lonza Group AG, Koninklijke DSM N.V., Biocon Limited, Ajinomoto Co., Inc., Evonik Industries AG, Intralytix, Inc., UAS Laboratories LLC, Second Genome, Inc., Chr. Hansen Holding A/S, Ginkgo Bioworks, Amyris, Inc., Lesaffre, BioVectra Inc.TerraVia Holdings, Inc., and others.
According to DelveInsight's analysis, The microbial fermentation technology market is experiencing notable growth, primarily due to the increasing incidence of chronic illnesses…
Hidradenitis Suppurativa Pipeline 2025: FDA Updates, Therapy Innovations, and Cl …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hidradenitis Suppurativa pipeline constitutes 24+ key companies continuously working towards developing 24+ Hidradenitis Suppurativa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Hidradenitis Suppurativa Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/hidradenitis-suppurativa-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hidradenitis Suppurativa Market.
The Hidradenitis Suppurativa Pipeline report…
Myasthenia Gravis Market to Expand Significantly by 2034, States DelveInsight Re …
The Key Myasthenia Gravis Companies in the market include - Hoffmann-La Roche, Janssen Research & Development, LLC, Immunovant Sciences GmbH, Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Argenx-Halozyme Therapeutics, Horizon Therapeutics, DAS Therapeutics, Chugai Pharmaceutical, Inc., Alexion, Regeneron Pharmaceuticals, Ra Pharmaceuticals, Inc., and others.
DelveInsight's "Myasthenia Gravis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myasthenia Gravis, historical and forecasted epidemiology as well as the Myasthenia Gravis…
More Releases for Peritoneal
Peritoneal Dialysis Solutions Market,2018 to 2028 by Segmentation Based on Produ …
Dialysis is a procedure of cleaning the blood in case of kidney failure and improper functioning of the kidneys. Two major types of treatments include hemodialysis and peritoneal dialysis. Where Peritoneal Dialysis Solution offers cleansing of blood out of the body along with the removal of extra fluid particles by utilizing the natural filter present in the body, the peritoneum membrane. Peritoneum membrane is the lining present in the surrounding…
Global Peritoneal Dialysis Market Study 2015-2025, by Segment (Peritoneal Dialys …
Peritoneal Dialysis is a way of dialysis that use the body's own peritoneal as the dialysis membrane. It makes the dialysis solution injected into the intraperitoneal, the use of the human body peritoneal filter, clear the blood of metabolic wastes and excess water, commonly known as "wash belly". It is one of the renal failure therapies outside of hemodialysis.
View TOC for Research Report @ https://www.researchgoal.com/reports/99SHea20181802328
The global Peritoneal Dialysis market will…
Peritoneal Dialysis Solutions Market to Witness Steady Growth through 2028(globa …
Dialysis is a procedure of cleaning the blood in case of kidney failure and improper functioning of the kidneys. Two major types of treatments include hemodialysis and peritoneal dialysis. Where Peritoneal Dialysis Solution offers cleansing of blood out of the body along with the removal of extra fluid particles by utilizing the natural filter present in the body, the peritoneum membrane. Peritoneum membrane is the lining present in the surrounding…
Peritoneal Cancer Market Report 2016-2022: by Type of Diagnosis,Treatment of Per …
Peritoneal cancer is a rare cancer that develops in peritoneum, a thin, dedicate sheet that lines the inside wall of the abdomen and covers the uterus and extends over the bladder and rectum. The peritoneum is made up of epithelial cells. The peritoneal cancer is resembles with epithelial ovarian cancer, which is the most common type of malignancy that affects the ovaries. Signs and symptoms for peritoneal cancer includes general…
Peritoneal Cancer Pipeline Review, H2 2017
"The Report Peritoneal Cancer - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritoneal Cancer - Pipeline Review, H2 2017, provides an overview of the Peritoneal Cancer (Oncology) pipeline landscape.
Peritoneal cancer is a rare cancer that develops in the peritoneum, a thin, delicate sheet that lines the…
Peritoneal Dialysis Market : Market and Growth Analysis
Dialysis refers to the process of cleaning the blood in case of kidney failure or improper functioning of kidneys. There are two types of dialysis; hemodialysis and peritoneal dialysis. Hemodialysis involves pumping out of the blood to an artificial kidney system and is returned back to the body with the help of tubing accessories. Peritoneal dialysis involves the cleansing of blood along with removal of extra fluids by utilizing body’s…
